Home » Topics » BioWorld Science

BioWorld Science
RSS

DTX-P7, a novel peptide-conjugated drug with efficacy in NSCLC

July 5, 2022

SERPINA1 is associated with poor prognosis and liver metastasis in gastric cancer

July 5, 2022

Knockout models may reveal role of CRIPTO in castration-resistant prostate cancer

July 5, 2022

ACT-02 improves neurodegeneration in mouse model of PD

July 5, 2022

New Gly12Cys mutant GTPase KRAS inhibitors patented by Abbisko Therapeutics

July 5, 2022

Jiangsu Zhengda Qingjiang Pharmaceutical presents SLC22A12 inhibitors

July 5, 2022

New protein kinase B inhibitors identified at Nanjing Zhengda Tianqing Pharmaceutical

July 5, 2022

University of Queensland, James Cook University describe new therapeutic peptides

July 5, 2022

Mindset Pharma discovers 5-HT2A receptor agonists

July 5, 2022

PTPRK predicts poor prognosis in patients with pancreatic cancer

July 5, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...